275 related articles for article (PubMed ID: 35018229)
1. Ferroptosis: a promising target for cancer immunotherapy.
Sun LL; Linghu DL; Hung MC
Am J Cancer Res; 2021; 11(12):5856-5863. PubMed ID: 35018229
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.
Wang Y; Sun Y; Wang F; Wang H; Hu J
Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
Li J; He D; Li S; Xiao J; Zhu Z
Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis and Triple-Negative Breast Cancer: A Systematic Overview of Prognostic Insights and Therapeutic Potential.
Khan M; Sunkara V; Yadav M; Bokhari SFH; Rehman A; Maheen A; Shehryar A; Chilla SP; Nasir M; Niaz H; Choudhari J; Anika NN; Amir M
Cureus; 2024 Jan; 16(1):e51719. PubMed ID: 38318597
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
Mokhtarpour K; Razi S; Rezaei N
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38874688
[TBL] [Abstract][Full Text] [Related]
7. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
[TBL] [Abstract][Full Text] [Related]
8. Targeting ferroptosis for cancer therapy: iron metabolism and anticancer immunity.
Luo L; Wang H; Tian W; Zeng J; Huang Y; Luo H
Am J Cancer Res; 2021; 11(11):5508-5525. PubMed ID: 34873476
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy.
Yang F; Xiao Y; Ding JH; Jin X; Ma D; Li DQ; Shi JX; Huang W; Wang YP; Jiang YZ; Shao ZM
Cell Metab; 2023 Jan; 35(1):84-100.e8. PubMed ID: 36257316
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.
Zhou Q; Meng Y; Li D; Yao L; Le J; Liu Y; Sun Y; Zeng F; Chen X; Deng G
Signal Transduct Target Ther; 2024 Mar; 9(1):55. PubMed ID: 38453898
[TBL] [Abstract][Full Text] [Related]
11. The mechanisms and therapeutic targets of ferroptosis in cancer.
Ye L; Jin F; Kumar SK; Dai Y
Expert Opin Ther Targets; 2021 Nov; 25(11):965-986. PubMed ID: 34821176
[TBL] [Abstract][Full Text] [Related]
12. Induction of ferroptosis by natural phenols: A promising strategy for cancer therapy.
Zhang Y; Xie J
Phytother Res; 2024 Apr; 38(4):2041-2076. PubMed ID: 38391022
[TBL] [Abstract][Full Text] [Related]
13. PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis.
Wang Z; Li R; Hou N; Zhang J; Wang T; Fan P; Ji C; Zhang B; Liu L; Wang Y; Kong J; Yao Q; Duan J; Zhao G; Ling R; Zhang J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37380368
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
Gu X; Liu Y; Dai X; Yang YG; Zhang X
Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy.
Liu Y; Duan C; Dai R; Zeng Y
Front Cell Dev Biol; 2021; 9():739392. PubMed ID: 34796174
[TBL] [Abstract][Full Text] [Related]
16. Role of GPX4 in ferroptosis and its pharmacological implication.
Seibt TM; Proneth B; Conrad M
Free Radic Biol Med; 2019 Mar; 133():144-152. PubMed ID: 30219704
[TBL] [Abstract][Full Text] [Related]
17. High Intensity Focused Ultrasound-Driven Nanomotor for Effective Ferroptosis-Immunotherapy of TNBC.
Yu X; Li X; Chen Q; Wang S; Xu R; He Y; Qin X; Zhang J; Yang W; Shi L; Lu L; Zheng Y; Pang Z; Peng S
Adv Sci (Weinh); 2024 Apr; 11(15):e2305546. PubMed ID: 38342612
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis and its emerging role in tumor.
Wang X; Liu Z; Ma L; Yu H
Biophys Rep; 2021 Aug; 7(4):280-294. PubMed ID: 37287758
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy.
Zhou Z; Xu B; Hu N; Guo Z; Bao W; Shao B; Yang W
Front Biosci (Landmark Ed); 2022 Jun; 27(7):203. PubMed ID: 35866391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]